Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03886311
Title Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma (TNT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Oncology Research Center, LLC
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.